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Background: There is increasing evidence of the importance of copy number variants (CNV) in genetic diversity
among individuals and populations, as well as in some common genetic diseases. We previously characterized a
common 32-kb insertion/deletion variant of the PSORS4 locus at chromosome 1q21 that harbours the LCE3C and
LCE3B genes. This variant allele (LCE3C_LCE3B-del) is common in patients with psoriasis and other autoimmune
disorders from certain ethnic groups.
Results: Using array-CGH (Agilent 244 K) in samples from the HapMap and Human Genome Diversity Panel (HGDP)
collections, we identified 54 regions showing population differences in comparison to Africans. We provided here a
comprehensive population-genetic analysis of one of these regions, which involves the 32-kb deletion of the
PSORS4 locus. By a PCR-based genotyping assay we characterised the profiles of the LCE3C_LCE3B-del and the
linkage disequilibrium (LD) pattern between the variant allele and the tag SNP rs4112788. Our results show that
most populations tend to have a higher frequency of the deleted allele than Sub-Saharan Africans. Furthermore, we
found strong LD between rs4112788G and LCE3C_LCE3B-del in most non-African populations (r2 >0.8), in contrast to
the low concordance between loci (r2 <0.3) in the African populations.
Conclusions: These results are another example of population variability in terms of biomedical interesting CNV.
The frequency distribution of the LCE3C_LCE3B-del allele and the LD pattern across populations suggest that the
differences between ethnic groups might not be due to natural selection, but the consequence of genetic drift
caused by the strong bottleneck that occurred during “out of Africa” expansion.
Keywords: Copy number variants, Psoriasis, Autoimmune disorders, LCE3C_LCE3B-del, Genetic variation,
Genetic drift, Human populationsBackground
Structural variants, largely represented by copy number
variants (CNV), are a rich source of genetic polymorph-
ism and they may potentially have a strong impact on
genetic diversity among individuals [1-3]. The biological
importance of CNV has become increasingly apparent
through the application of various comprehensive and
complementary approaches to analyse CNV, including
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distribution, and reproduction in any mediummore recently, next-generation sequencing (NGS) tech-
nologies [2-9]. The functional impact of CNV has been
demonstrated at all biological levels [10], from cellular
effects on gene expression [11] to their association with
several types of complex traits and genetic diseases
[12-17], as well as with different types of cancers [18-20].
Human population genetics studies allow major popu-
lation branches and subpopulation groups to be defined
[21], for which excellent resources are now available,
such the Human Genome Diversity Panel (HGDP) [22]
and HapMap Collection [23]. The analyses of the human
genome at the nucleotide and structural levels have
shown that genetic clusters closely correspond to groupsntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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over, several studies have reported CNV containing re-
gions that show population differences in copy number
[25-27]. These examples suggest that genetic differences
between ethnic groups involving large genomic regions
affect functional elements influenced by the environ-
ment, which are therefore potential substrates for natu-
ral selection.
We recently characterized a common 32-kb deletion
in the PSORS4 locus on chromosome 1q21 that har-
bours the LCE3C and LCE3B genes. The deleted allele
(LCE3C_LCE3B-del) is common in patients with psoria-
sis among populations of European ancestry [16,28,29],
and in Chinese and Mongolian populations [29-31]. In
addition, successive studies also found this deletion to
be associated to rheumatoid arthritis in Spanish and
Chinese patients [32,33], psoriatic arthritis in Spanish
and Italian populations [34], and systemic lupus erythe-
matous in Chinese patients [33].
Differences in the frequency of LCE3C_LCE3B-del and
its relationship to disease in different ethnic groups sug-
gest a possible role of environmental factors and demo-
graphic history on this polymorphic deletion and on its
associated diseases. In fact, the diseases associated with
LCE3C_LCE3B-del are generally regarded as immuno-
logical disorders, the aetiology of which is influenced by
both environmental (infection, drugs, stress and climate)
and genetic factors [35]. As such, we might expect a
variable frequency of the polymorphisms around the
world. By better understanding the genetic variability of
LCE3C_LCE3B-del in populations associated with dis-
tinct environments and with other specific demographic
histories, we might gain insight into the interaction be-
tween some of the multiple components involved in sev-
eral complex diseases.
Here we have used array comparative genomic hyb-
ridisation (aCGH) to characterize the profile of inter-
population differences of the LCE3C_LCE3B-del allele in
13 population groups from the HapMap and Human
Genome Diversity Panel (HGDP) collections, and of the
LCE3C_LCE3B-del and tag SNP rs4112788 association
[16] across 31 ethnic groups from the HGDP. The re-
sults provide a comprehensive view of the population
distribution of this common functional CNV, suggesting
that genetic drift caused by strong bottleneck occurred
during the “out of Africa” has established this common
deletion at high frequencies in most of non-Sub-Saharan
African populations.
Results
Identification of population specific CNV using aCGH
Following the criteria described for CNV detection (see
Additional file 1), we observed 54 regions at least 30-kb
long whose signal intensities (i.e. copy number) indicateda distinct distribution in at least one of the 12 popu-
lations when compared to the Yoruba (YRI) popula-
tion (Additional file 2: Figure S1 and Additional file 3:
Table S3). Populations from Eastern-Asia, America and
Oceania had greater differences in signal intensity with
respect to the YRI population than other Sub-Saharan
African, European, Northern African and Middle East
populations, as well as more copy-number variable re-
gions (Additional file 2: Figure S2), consistent with previ-
ous studies of human populations [24,36-40].
All 54 regions for which a difference in intensity could
be observed in a population corresponded to known
CNV described in the Database of Genomic Variants
(http://projects.tcag.ca/variation/). Of these 54 regions,
36 (67%) totally or partially overlapped with 58 RefSeq
genes, indicating that the variation in CNV between po-
pulation groups involves functional elements, in agree-
ment with previous data, and indicating a significant
relationship between the genomic regions affected by
CNV and gene content [1,3]. In addition, 39 out of 54
regions (72%) are enriched in segmental duplications
(SD), also consistent with previous studies [1,3,5,41,42]
(Additional file 3: Table S3).
We first carried out a Gene Ontology (GO) analysis
(www.geneontology.org/) of the variable genomic regions
that contain known genes to select categories of enriched
genes with p-values below 0.01. Our set of genes was sig-
nificantly enriched in proteins related to the response to
environmental stimulus (sensory perception of chemical
stimulus [adjP = 0.0002]), the immune system (antigen
processing and presentation [adjP = 0.0002]) and metabo-
lism (carboxylase activity [adjP = 0.007]). Relaxing the
p-values to 0.05, we also found enrichment in keratinisa-
tion (adjP = 0.0352), the category represented by LCE3C
and LCE3B genes.
Several CNV that show variable signal intensity across
populations contain genes known to be associated with
disease (Additional file 3: Table S3), indicating that popu-
lation adaptation to different environments could entail
effects on pathological mechanisms. Although in this
study we focused on the variability of the LCE3C_LCE3B-
del among populations due to its association with the sus-
ceptibility to psoriasis and other autoimmune diseases in
some ethnic groups, other copy number variant regions
contain genes that deserve further attention at the popula-
tion genetics level. For example, CFHR3 and CFHR1 are
associated with age-related macular degeneration [43-45]
and systemic lupus erythematous [46]. GSTT1 has been
linked to breast cancer [47], NAFLD to non-alcoholic fatty
liver disease [48], and HLA-DRB5 and HLA-DQA1 to
autoimmune diseases [49,50]. Due to their functional
characteristics, most of these genes are very appealing
from both biomedical and evolutionary perspectives,
supporting the idea that the variable prevalence of some
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mental conditions.
Analysis of the LCE3C_LCE3B-del frequency in worldwide
populations
The aCGH data for the LCE3C_LCE3B-del showed lo-
wer intensity values for all the studied populations re-
spect to YRI, and five of them (Pima (PIMA), Brahui
(BRA), Mozabite (ALG), Maya (MAYA) and Chinese
Han (CHB)) presented log2 ratios ≤0.25, limit considered
significantly low for a copy-number loss by our algorithm
(Table 1, Additional file 1). This suggests that not only
there is a high frequency of the deletion in European
and Asian populations when compared to Africans,
as shown previously [16,30,31], but other population
groups are also likely to have higher frequencies of
the LCE3C_LCE3B-del.
The Agilent H244K array contains six probes covering
the 32 kb deletion involving the LCE3C and LCE3B
genes, that has been associated with psoriasis and other
autoimmune diseases [16,28,29,32,33]. To evaluate the
reliability of the CNV analysis by aCGH in this region
we expanded the analysis of LCE3C_LCE3B-del by using
8 additional probes, 4 on each side. Only three probes of
the deleted region (involving LCE3C) consistently and
reliably detected the LCE3C_LCE3B-del (Additional file 2:
Figure S3). Although the variable probe intensities might
suggest population-specific breakpoints for this CNV, it isTable 1 Comparison of LCE3C_LCE3B-del aCGH values with LC
populations
Geographic Region Population (ID) aCGH intensity va
(respect to YRI*)
Sub-Saharan Africans Pygmies* (PYG) −0.13
Yoruba (YRI) 0*
Bantu (BAN) −0.03
North-Africans/Middle East Mozabite*# (ALG) −0.3
Bedouin* (BED) −0.21
Europians French (FRA) −0.2
Southern Asians Brahui# (BRA) −0.31
Hazara (HAZ) −0.15
Eastern Asians Han# (CHB) −0.26
Yakut* (YAK) −0.12
Oceania Papuan-Melanesian (OCE) −0.18
Americans PIMA# −0.67
MAYA# −0.27
Comparison of aCGH log2 ratio values for each population analysed in the array aga
found by PCR, and with the genotype frequency of tag SNP rs4112788.
*Isolated populations.
# Populations with values significantly low for a copy-number loss by our algorithmmost plausible that these differences reflect the variation
in the hybridization efficiency of the probes in the array.
We individually genotyped the LCE3C_LCE3B-del for
all the samples available from the 13 populations used in
the aCGH analysis. There was good concordance of the
aCGH intensity data in pooled population samples with
direct PCR analysis of the LCE3C_LCE3B-del in indivi-
dual samples, showing a lower frequency of the deletion
in the samples with weak hybridization signals with
respect to the YRI population (Table 1). In particular,
the correlation (Spearman rho coefficient) between the
aCGH log2 ratio values and the frequency of deleted al-
lele was 0.857 (p-value = 0.0002). The highest frequency
of the deletion was detected in the PIMA population,
with an allele deletion frequency of 75% (log2 ratio in
the sample pool of −0.67). The ALG population also had
a high frequency of the LCE3C_LCE3B-del (67% with an
intensity log2 ratio of −0.30). As expected from the
aCGH data, Sub-Saharan populations have low frequen-
cies of the deleted allele (28% in Bantu (BAN), 34% in
YRI, and 35% in Pygmies (PYG)). However, two Asian
populations (Hazara (HAZ) and Yakut (YAK)) have a
LCE3C_LCE3B-del frequency lower than that of Sub-
Saharan Africans (21% in HAZ and 23% in YAK),
although the small number of samples for these two
population groups (17 and 11 samples) made the estima-
tion of their low frequency unreliable. The frequency of










lues +/+ +/− −/− + − AA AG GG
38.6 52.3 9.1 64.77 35.23 0 13.64 86.36
36.4 59.1 4.5 65.91 34.09 0 28.57 71.43
44.4 55.6 - 72.22 27.78 0 50.00 50.00
11.5 42.3 46.2 32.69 67.31 0 21.43 78.57
19.4 55.6 25 47.22 52.78 14.63 53.66 31.71
22.2 37 40.7 40.74 59.26 16.67 41.67 41.67
22.7 40.9 36.4 43.18 56.82 21.74 43.48 34.78
58.9 41.1 0 79.41 20.59 43.75 56.25 0
14.7 47.1 38.2 38.24 61.76 0 52.17 47.83
63.6 27.3 9.1 77.27 22.73 50.00 31.82 18.18
31.4 37.1 31.4 50.00 50.00 26.47 41.18 32.35
9.1 31.9 59.1 25.00 75.00 9.09 36.36 54.55
9.5 57.1 33.3 38.10 61.90 7.14 57.14 35.71
inst the Yoruba population with the CNV genotypes and allele frequencies
.
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Weinberg equilibrium for each of the 13 populations
and no significant deviations were observed, suggesting
that genotyping errors were scarce (Tables 1 and 2).
We then evaluated the frequency of LCE3C_LCE3B-
del in almost all available samples from the HGDP, re-
presenting a large worldwide diversity (768 genotyped
samples from 31 populations). LCE3C_LCE3B-del was
found to be common in most populations even though
in a heterozygous state (Figure 1). By contrast, remar-
kable differences between groups were observed in theTable 2 LCE3C_LCE3B-del and rs4112788G genotype frequenc
Main Geographic Region Populations (ID) Individuals HWE
x2
Sub-Saharan Africans Pygmies* (PYG) 44 0.93
Mandenka (MAN) 17 0.78
Yoruba (YRI) 22 2.18
Bantu (BAN) 18 2.66
North-African/Middle East Mozabite* (ALG) 26 0.04
Bedouin* (BED) 36 0.47
Druze* (DRU) 37 1.87
Palestinian (PAL) 40 0.44
European French (FRA) 27 1.47
French Basque* (BASQ) 21 1.70
Sardinian* (SARD) 24 0
Italian (ITL) 17 0.28
Orcadian* (ORC) 16 2.80
Russian (RUS) 23 0.18
Central-South Asians Brahui (BRA) 22 0.61
Balochi (BAL) 18 0.21
Makrani (MAK) 24 0.67
Sindhi (SIN) 21 1.71
Kalash* (KAL) 24 1.53
Burusho (BUR) 23 3.19
Hazara ( HAZ) 17 1.14
Eastern Asians Han (CHB) 34 0
Japanese (JPN) 26 2.45
Yaut* (YAK) 11 0.55
NEA 34 0.54
SEA 36 0.73
Oceania Papuan-Melasian (OCE) 35 2.31
Americans PIMA 22 0.51
MAYA 21 0.94
Karitiana (KAR) 17 0.02
Surui* (SUR) 15 1.52
*Isolated populations.
Allele and SNP genotype frequencies for all populations analysed, and the r2 valuehomozygote frequency of the deleted and non-deleted
alleles. Apart from a few populations, Sub-Saharan
Africans tend to have a lower frequency of the deleted
allele in the homozygous state, which was significantly
higher in the rest of the populations (Figure 2). Hence,
excluding the few exceptional populations, these results
generally suggest a possible non-Sub-Saharan African
sweep for this locus. Thus, it is possible that the homo-
zygous deletion has swept almost to fixation in mostly
non-Sub-Saharan African populations, probably as a






p-value + − AA AG GG r2
0.33 64.77 35.23 0 13.64 86.36 0.013
0.56 58.82 41.18 4.55 22.73 72.73 0.121
0.14 65.91 34.09 0 28.57 71.43 0.089
0.10 72.22 27.78 0 50.00 50.00 0
0.84 32.69 67.31 0 21.43 78.57 0.256
0.49 47.22 52.78 14.63 53.66 31.71 0.772
0.17 36.49 63.51 9.09 56.82 34.09 1
0.50 31.25 68.75 4.44 44.44 51.11 0.936
0.23 40.74 59.26 16.67 41.67 41.67 1
0.19 40.48 59.52 9.09 54.55 36.36 0.91
0.97 29.17 70.83 13.04 47.83 39.13 1
0.60 31.76 38.24 35.00 40.00 25.00 1
0.09 31.25 68.75 23.08 23.08 53.85 1
0.68 39.13 60.87 14.29 42.86 42.86 0.897
0.44 43.18 56.82 21.74 43.48 34.78 1
0.65 27.78 72.22 5.00 40.00 55.00 0.852
0.41 50.00 50.00 23.81 42.86 33.33 0.55
0.19 33.33 66.67 0 50.00 50.00 0.905
0.22 47.92 52.08 16.67 55.56 27.78 0.861
0.07 41.30 58.70 27.27 31.82 40.91 1
0.29 79.41 20.59 43.75 56.25 0 0.904
0.98 38.24 61.76 0 52.17 47.83 0.468
0.12 48.08 51.92 50.00 37.93 37.93 0.837
0.46 77.27 22.73 50.00 31.82 18.18 1
0.46 45.59 54.41 20.59 52.94 26.47 0.852
0.40 29.17 70.83 5.88 50.00 44.12 0.537
0.13 50.00 50.00 26.47 41.18 32.35 0.935
0.48 25.00 75.00 9.09 36.36 54.55 0.804
0.33 38.10 61.90 7.14 57.14 35.71 1
0.90 97.06 2.94 90.48 4.76 4.76 1
0.22 26.67 73.33 10.53 26.31 63.16 1
obtained in the linkage disequilibrium analysis.
Figure 1 Global distribution of the genotype frequencies for the LCE3C_LCE3B CNV. The LCE3C_LCE3B-del is found in all the populations
studied, mostly in the heterozygous state (yellow). The frequency of LCE3C_LCE3B-del in the homozygous state (blue) is higher in most non-Sub-
Saharan African populations, with the exception of few ethnic groups. By contrast, the non-deletion homozygous state (red) tends to be more
frequent in Sub-Saharan Africans, with the exception of few ethnic groups (KAR, ITL and YAK).
Figure 2 Global distribution of allele frequencies for LCE3C_LCE3B CNV. The deleted allele (blue) is more frequent in non-Sub-Saharan
African populations than in Sub-Saharan Africans, with the exception of some ethnic groups (KAR, ITL and YAK).
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frequency of LCE3C_LCE3B-del (3%) was found in the
Karitiana (KAR) population from the Amazon region of
Brazil.
The small sample sets of some of the populations
studied here may be responsible for dramatic differences
observed in the frequencies of the LCE3C_LCE3B-del
between populations, such as the Surui (SUR), KAR and
YAK. However, these ethnic groups are geographically
isolated and they are less likely to have suffered genetic
mixture from other populations. It is known that specific
demographic histories may be key factors to explain al-
lele frequencies among human ethnic groups [51,52] and
therefore, small geographic clines could be caused by a
long-standing history of spatially restricted gene flow.
This would imply that although there are continental-
scale clusters or general selective sweeps, such as the
non-Sub-Saharan African sweep, allele frequencies
change gradually on small geographic scales. Thus, the
populations that we found to have exceptional frequen-
cies of the deleted or non-deleted allele could represent
a clear example of a particular genetic drift or relatively
recent selection event that generated extremely large
differences.
Linkage disequilibrium of LCE3C_LCE3B-del with a
neighbouring SNP
We evaluated the linkage disequilibrium (LD) between
the tag SNP rs4112788 and the LCE3C_LCE3B 32-kb de-
letion [16] in all the populations analysed. We found
that rs4112788A is associated with the non-deleted CNV
allele in all cases, while rs4112788G can be associated
with both CNV non-deleted and deleted alleles. While
the first case is valid for all the populations analysed, the
latter association differed between groups.
There is a high frequency of homozygosity for
rs4112788G in sub-Saharan African individuals but not
for the LCE3C_LCE3B-del (Figure 2, Table 1). This re-
sults in the lowest LD between rs4112788G and
LCE3C_LCE3B-del, ranging between 0.01 and 0.12. The
high frequency of rs4112788G in the ALG popula-
tion was correlated with a higher frequency of the
LCE3C_LCE3B-del, even though the r2 value remains
low (0.26). We found a high concordance between the
frequency of rs4112788G and the LCE3C_LCE3B-del in
most of the other populations, with r2 values >0.8 in
most of them. Some exceptions with r2 values around
0.5 were the CHB (0.47) and South East Asians (0.54),
YAK, Makrani (MAK) and HAZ populations (Table 2).
Discussion
In this study, we first documented the distribution of re-
gions with variable copy number between twelve popu-
lations, comparing them with a Sub-Saharan Africanpopulation (YRI) by aCGH, and using two independent
CNV algorithms. We used stringent criteria to define a
CNV based on the log2 ratios above 0.25 (both direct
and dye-swap labels) for 3 consecutive probes in at least
one of the comparison experiments, and concordance
with the two CNV algorithms. We focussed on CNV of
at least 30-kb in order to identify relative large polymor-
phisms that could present a specific pattern of variation
among human populations.
Previous studies of samples in the HapMap collection
and the HGDP panel highlighted a gradual decrease in
genetic diversity in function of the distance from Sub-
Saharan Africa [24,36-40], a result that reflects the in-
fluence of geography on human genetics and that is
consistent with the serial-founder model of human ex-
pansion out of Sub-Saharan Africa. These African popu-
lations have the highest degree of heterozygosity in most
genomic regions, while populations from America and
Oceania present the lowest intra-population variance. By
using a pooled approach we looked to dilute intra-
population differences and to enhance inter-population
variability. Hence, comparing different pools of indivi-
duals from different populations with a pool from an
African population, we expected to find more CNV as
the geographic distance from Africa increases. Indeed,
we found 54 loci that show structural variation in the
form of CNV in worldwide populations (Additional file 2:
Figure S1), most specifically in populations from America
and Oceania, followed by Eastern Asian and Western
Asian populations (Additional file 2: Figure S2).
Interestingly, we found an enrichment of segmental
duplications (SD) in the loci detected and 58 known
genes totally or partially overlapping some CNV regions
(Additional file 3: Table S3). Most of these genes are in-
volved in sensory perception, the immune system and
distinct metabolic pathways, and some are associated
with disease. These results are consistent with previous
reports [1,3], and they clearly support the idea that
population-specific CNV profiles could explain adapta-
tions to environmental pressure and differences in dis-
ease prevalence among populations.
Due to the significant association of LCE3C_LCE3B-
del to the susceptibility to some autoimmune diseases
that have a higher prevalence in some populations from
developed countries, such as psoriasis, we expected to
find differences in the frequency of the deletion among
populations with different geographic origins and demo-
graphic histories. Re-analysing the aCGH data for the
LCE3C_LCE3B region, we observed differences in signal
intensity in a region smaller than the 6 probes that cover
the 32-kb deletion. This could suggest population diffe-
rences in the CNV breakpoints, particularly since the
Database of Genomic Variants currently lists more than
25 distinct large structural variants that span either the
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breakpoint coordinates used in our study correspond to
one deletion identified for the first time in a European
population. However, the same breakpoints were also
used successfully in some Asian groups. Furthermore, it
is important to consider that some of the probes in the
array might not be absolutely specific and they may hy-
bridise to similar sequences, probably other LCE genes,
masking the signal from similar regions. Indeed, it is
known that ascertaining CNV by aCGH is complicated
due to poor power and non-trivial rates of false positives.
Moreover, using genome-wide scanning techniques to
detect CNV, like the Agilent H244k aCGH array, have a
limited capacity to characterize specific breakpoints. In a
population survey of the frequency of the deletion by
PCR, we could amplify the deleted and non-deleted al-
lele in all populations and samples, which confirms the
limited power of the aCGH platform to characterize spe-
cific breakpoints. Although other unmeasured CNVs
may affect this region in some populations, our analysis
indicates that the specific deletion studied here may be
the predominant one in most populations.
We found most populations to have a high percentage
of the deleted allele, mostly in the heterozygous state,
with the exception of some isolated instances and
Karitiana population, which present a high number of
relatives pairs that could reduce the representativeness
of allele and genotype frequencies in this population
[53]. The aCGH results indicate that most populations
tend to have a higher frequency of the deleted allele than
Sub-Saharan Africans. The high frequency of the dele-
tion could reflect some selection for the deletion among
human populations, even though it has recently been de-
scribed as a susceptibility factor for psoriasis and other
autoimmune diseases [16,29,32-34]. Thus, the 32-kb
LCE3C_LCE3B-del could offer protection against an un-
known element, and its role as a susceptibility factor for
autoimmune inflammatory diseases may be a “new” con-
sequence of this earlier adaptation. In other words, the
LCE cluster could had been subjected to natural selec-
tion at different times during human evolution, and a
partial sweep of the deletion could occur if individuals
carrying the deleted allele had greater resistance to spe-
cific pathogens (for example). In such scenario, however,
the fitness advantage would have to outweigh the loss of
the LCE3C_LCE3B genes and the potential regulatory
changes of the LCE cluster incurred by disruption to the
surrounding genomic region. A similar scenario has
been put forward for rearrangements associated with the
alpha-globin gene family, where recurrent deletions of
HBA1 and HBA2 associated with alpha-thalassemia have
reached a high frequency in Mediterranean and Pacific
populations [54]. Moreover, it is important to take
into account that the autoimmune diseases related toLCE3C_LCE3B-del are also thought to be associated
to other genetic variants [55-57], and that an important
environmental component is involved in these disorders
[58-61]. Thus, LCE3C_LCE3B-del only represents another
genetic factor involved in susceptibility to these diseases,
together with environmental factors like infections, drugs,
stress, smoking and climate.
Populations in the HGDP have different sample sizes
and, in some of them, first and/or second degree rela-
tives pairs have been detected [53], which could both in-
fluence the estimation of the true values of allele and
genotypes frequencies that underlie several studied pop-
ulations. Furthermore, they present different demo-
graphic histories, and all these factors may also affect
the power to detect selection. We should take into
account the possibility that genetic differences among
human populations could be caused by neutral demo-
graphic processes, such as “allele surfing”. This phe-
nomenon is the result of the intense amount of genetic
drift produced by strong bottlenecks that occurred du-
ring the exit “out of Africa”, which was followed by a
spatial expansion that could lead to the geographic
spread of an allele and increase its frequency in newly
colonised areas [62]. This neutral process has recently
received special attention due to its consequences for al-
lele frequencies that appear to reflect a selective process.
Thus, a definitive evidence of the influence of the nat-
ural selection on genetic population differences it is not
currently available. For example, two reports described
an increase in the frequency of a derived allele outside
Africa for two genes involved in the control of brain size
(MCPH1 and ASPM), and high LDs [63,64]. It was pro-
posed that the derived haplotypes might be under local
positive selection in non-African populations, although
it was recently demonstrated that neutral allele sur-
fing could generate similar geographic distributions
of allele frequencies during the range expansion of
Africa [65].
It is clear that the deleted allele has been established
in most world populations, which probably has some
kind of functional consequences. Expression of the
LCE3C and LCE3B genes is induced upon epidermal ac-
tivation as a consequence of inflammation or skin dis-
ease [16]. However, the high frequency of the deletion
worldwide suggests the existence of some redundancy in
the function of LCE genes in this cluster. It is possible
that other genes fulfil the function of LCE3C and LCE3B,
although imperfectly, contributing to the abnormal dif-
ferentiation and epidermal hyperproliferation character-
istic of psoriatic lesions. Thus, when other susceptibility
components are not present, the deletion is insufficient
to produce the abnormal phenotype but when several
susceptibility components concur, the LCE3C_LCE3B-
del could lead to disease development.
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associated with psoriasis in several populations of
European ancestry, 14 SNPs were found related with
LCE3C_LCE3B-del, with allele G at rs4112788 being the
only one in strong LD [16]. Despite we could contemplate,
a priori, the possibility that the association between these
SNPs and the LCE3C_LCE3B-del could vary among popu-
lations, a strong LD between a given SNP and CNV sug-
gest a single origin of both variants. For this reason we did
not expect to find strong association between other SNPs
and the LCE3C_LCE3B-del in other populations.
A strong LD might be also a common feature of a
biallelic CNV, which is particularly useful in association
studies for complex disorders in which the redundancy
of information implied by LD can be used to optimize
genotyping. Nevertheless, this might not be useful in as-
sociation studies of all populations, since LD patterns
vary among populations of different geographic origin
and a much higher proportion of r2 variance could be at-
tributed to differences between continental regions [66],
with similar characteristics found in CNV. Specifically,
increases in LD as the geographic distance from East
Sub-Saharan Africa augments have been reported, with
the highest values occurring in the Americas, followed
by Oceania, East Asia, Eurasia and Africa. As for CNV,
this pattern matches the prediction from a model of se-
quential founder effects during spatial expansion from
Africa, given that such founder effects would be ex-
pected to increase the LD at each step of the expansion
[24,67].
Our results for LCE3C_LCE3B-del are consistent with
previous studies showing that the extent of LD in non-
Africans is higher than in Africans [68], reflecting the
origin and spread of modern humans from Africa. We
found r2 values >0.8 in all non-African populations with
the exception of two Chinese groups (CHB and popula-
tion grouped as SEA) and the Makrani population. Al-
though these exceptions are not defined as “isolated” in
the HGDP, they may reflect a particular demographic
and genetic history of these populations or alternatively,
a bias due to the small number of individuals from these
populations in the study. However, the LD pattern be-
tween rs4112788G and LCE3C_LCE3B-del found for all
populations differs from other studies. While the trend
observed for general LD consists of a successive increase
in the LD in Middle East-North Africa, Central South
Asia, Europe, East Asia, Oceania and America with re-
spect to Sub-Saharan Africa, we essentially detect low r2
values in African populations and similar high values for
the rest of the world.
Conclusions
Our results show a rise in the number of CNV as the
geographic distance from Africa increases, reflecting theinfluence of geography on human genetics. The higher
frequency of LCE3C_LCE3B-del found in most of non-
Sub-Saharan African populations suggests the fixation of
the deleted allele as a consequence of the genetic drift
that occurred during the exit from Africa. The CNV de-
leted allele has been associated with susceptibility to
autoimmune diseases, not only implying that natural
selection but that neutral demographic processes can de-
fine the differences in disease frequencies and pheno-
typic diversity among human populations.
Population genetics has the power to provide insights
into the demographic history of populations, the selec-
tive pressures acting on genetic variation and the muta-
tional processes generating diversity. With NGS able to
precisely define the many types and forms of CNV, and
other structural variations, we would expect a rapid ad-
vance in the discovery and characterisation of novel vari-
ants over the next few years. The analysis in patient
samples and in subjects of different populations will de-
fine their evolutionary history and/or their role in hu-
man adaptation and disease.
Methods
Array comparative genomic hybridisation (aCGH)
To investigate the variability of CNV in human popula-
tions we used the Human Genome CGH Microarray Kit
244 k (Agilent Technologies Inc, Santa Clara, CA, US),
which contains over 244,000 probes and covers the en-
tire genome at 10 kb resolution. The initial detection of
CNV was performed using a DNA-pooling approach.
Experiments were performed in duplicate with DNA la-
belling colour reversal (dye-swap). The specific experi-
mental protocol that we used was based on the Agilent
Oligonucleotide Array-Based CGH for Genomic DNA
Analysis.
We selected 86 DNA samples from two populations of
the HapMap Collection and 343 DNA samples from 21
ethnic groups of the Human Genome Diversity Panel-
Centre d’Etude du Polymorphisme Humain (HGDP-
CEPH) grouped into 11 populations. Each population
group contained samples from 20 to 50 individuals
(Additional file 4: Table S1 and Additional file 1). We
generated 13 DNA pools (one for each population),
which included all the samples available for each popula-
tion group (the data analysis procedure is explained in
the Additional file 1). The final DNA concentration of
the pooled samples was measured on a NanoDropW ND-
1000 UV–vis Spectrophotometer (Wilmington, Delaware,
USA), and DNA integrity was evaluated by electrophoresis
in alkaline gels.
Analysis of gene content in regions found by aCGH
CNV gene content was determined with the RefSeq gene
annotation from the UCSC Genome Browser. To measure
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population differences in comparison with the rest of
genes in the human genome, we analysed the enrichment
of GO categories using the Gene Set Analysis Toolkit V2
(http://bioinfo.vanderbilt.edu/webgestalt/).Multiplex PCR-based genotyping
To analyse the specific LCE3C_LCE3B-del region by
PCR, we used the same samples as those used in the
aCGH, with the exception of the two HapMap popula-
tions (YRI and CHB) that were replaced by samples of
the same ethnic group but from HGDP-CEPH (Yoruba
from Nigeria and Han Chinese). In addition, we included
25 new populations for this analysis, also from HGDP-
CEPH, grouped into 18 ethnic groups (Additional file 1).
Each population group had samples from between 17
and 44 individuals. In combining samples we took into
account the geographic location and proximity, grouping
small numbers of individuals from different populations
(mostly Chinese samples). Information about the groups,
their identification (ID) and the number of samples are
shown in the Additional file 1 and Additional file 5:
Table S2. For the CNV genotyping assay, we used indi-
vidual samples instead of pools in order to determine
not only the inter-population differences but also, the
intra-population variability.
The LCE3C_LCE3B-del region, encompassing 32,199 bp
(chr1:150,822,166-150,854,365 in hg18) was genotyped by
multiplex PCR with 50FAM modification, subsequent ca-
pillary electrophoresis and Gene Mapper analysis (Gene
Mapper v.4.0, Applied Biosystems), as described previ-
ously [16]. Briefly, the DNA template was amplified simul-
taneously with two forward and two reverse primers, and
the PCR products were diluted, added to a formamide-
ROX mixture and subsequently resolved by capillary elec-
trophoresis (3730xl DNA Analyzer; Applied Biosystems).
Correlation between CNV deletion and aCGH was ex-
plored using the Spearman Rho test (Stata v10 software).SNP genotyping assay
The rs4112788 SNP was genotyped using a C_31910050_
10 TaqManW Pre-Designed SNP Genotyping Assay
(Applied Biosystems, Foster City, CA). PCR amplification
was performed according to the product specifications
and alleles were discriminated on a 7900HT Fast Real-
Time PCR system, analysing the data with SDS 2.3 pack-
age (Applied Biosystems). When genotyping the SNP, a
total of 56 samples from different populations were no
longer available due to the poor quality of the DNA and
therefore, they were not analysed (Additional file 5: Table
S2). LD Measurements and haplotype association statistics
were calculated using Haploview software.Additional files
Additional file 1: Supplementary Methods.
Additional file 2: Supplementary Figures.
Additional file 3: Supplementary Table 3. Log2 ratio values for each
CNV locus (coordinates in hg18) in the populations analysed by aCGH
against the Yoruba population. Information about the genes and SD
overlapping these loci.
Additional file 4: Supplementary Table 1. Population used by aCGH
analysis.
Additional file 5: Supplementary Table 2. Population used in
LCE3C_LCE3B-del genotyping.
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